A New Vision of Transformative Medical Research via NIH to Make America Healthy Again

Robert F. Kennedy, Jr. has put NIH on notice. I see four research priorities and funding mechanisms to understand integration and create opportunities for the emergence of health.

I SEE FOUR PRIORITIES FOR TRANSFORMATIVE MEDICAL RESEARCH AND TRANSFORMATIVE MEDICINE: PREVENTING AND REVERSING IATROGENIC ILLNESS. MENTAL HEALTH CRISIS. METABOLIC DISORDER AND DIABETES. PREVENTING AND TREATING AUTOIMMUNE DISEASE.

We will set scientists free to be scientists and free physicians to be healers.

Robert F. Kennedy Jr. is making waves with a bold promise: if given authority, he would terminate 600 employees at the National Institutes of Health (NIH). For Kennedy, the proposal is a step toward holding NIH accountable, pushing the agency to move beyond bureaucratic stagnation toward results-driven, transparent, and impactful research. Critics argue the cuts would disrupt critical health research, but for advocates of reform, the proposal underscores the urgent need for a revitalized NIH—one that prioritizes public health and realignment of resources to serve Americans more effectively.

The new agency leadership’s goal will be to transform the nation’s health. I see four essential priorities: preventing, reversing, and treating iatrogenic illnesses caused by medical interventions, including vaccines; addressing the country’s mental health crisis; combating diabetes and metabolic disorders; and mitigating the rise of autoimmune diseases.

Imagine an NIH restructured around these core areas, using a streamlined approach that prioritizes comprehensive, integrative health. I see a path forward where NIH can contribute to a much healthier future via transformative research focused on the study of integrative therapies and biomarkers for individualized medicine. With a clear emphasis on transparency and unbiased science, my vision calls for strategic funding, the establishment of extramural, interdisciplinary Centers of Excellence, an expansion of extramural support to universities committed to objective research, and a commitment to translating discoveries into practical applications that improve the lives of millions.

In my view, reprioritizing funding toward these four areas would be NIH’s first major shift under this new vision. Iatrogenic illness—health complications stemming from medical treatments—demands our attention as rates of adverse drug effects, including those from vaccines, highlight the pressing need for more rigorous and transparent research. By prioritizing studies on medical safety and efficacy with objectivity and without regard to commercial influence, NIH can make lasting contributions to elevate the baseline of a new public health. By downsizing wasteful, ineffective internal programs, which are often rife with conflicts of interest and too little accountability, increased extramural funding to universities who commit to unbiased scientific inquiry will foster research that follows the evidence rather than existing narratives designed to bolster profit centers. This dynamic research environment would foster accountability, driving progress in treatments that are not only effective but also safe for the American public.

The mental health crisis in America is worsening by the day. Issues like anxiety, depression, ADHD, autism, and addiction create lasting impacts on individuals, families, and entire communities. NIH must prioritize mental health research that explores both traditional and non-traditional treatments, bringing together fields like psychiatry, psychology, neurobiology, and lifestyle medicine. Traumatic brain injury in sports is a silent epidemic that must be dealt with squarely. We must look beyond conventional treatments and embrace holistic, integrative methods that use knowledge of systems biology and that focus on the whole person, not just their symptoms. Dietary interventions, behavioral therapies, and mind-body practices used in combination with naturopathic therapies, OTC drugs and key pharmaceuticals - existing and new - will provide new, multifaceted solutions to longstanding mental health challenges. By investing in comprehensive care approaches, NIH could shift the mental health landscape from one of reactive treatment to one of proactive, sustained well-being.

Metabolic disorders, including diabetes, are another critical target. Their rising prevalence represents both a public health and economic crisis, straining individuals and the healthcare system alike. Here, NIH’s research funding would be directed toward shutting down autoimmunologic and other root causes of metabolic disroders and diseases, preventative and lifestyle-focused initiatives, and the use of tools like neurofeedback to help patients adhere to their lifestyle changes. Studies on diet, exercise, and social determinants of health could help turn the tide of diabetes and related conditions by targeting root causes and external inputs rather than merely managing symptoms. As FDA updates policies on nutrition and refocused attention on toxins in foods, efforts funded by the NIH will have more impact. Additionally, regenerative wellness research—focusing on potential ways to reverse the effects of metabolic disease—will revolutionize care and reduce the incidence of these chronic conditions. The goal is clear: empower Americans with effective strategies to avoid disease altogether, rather than relying on lifelong pharmaceutical management.

Autoimmune diseases plague Americans, too, and they are often difficult to treat, leaving patients to manage a lifetime of chronic symptoms. To meet this challenge, NIH would channel resources into research that digs deep into the origins of autoimmune disease, examining genetic predispositions, environmental triggers, including pathogenic priming, food sensitivities, and ways to use our knowledge of immunology to take steps like reversing Th2 skew. Current treatments often address symptoms but ignore the underlying immune dysregulation, making symptom management an endless cycle for many. Aluminum in vaccines will be in the crosshairs.

NIH’s focus would shift toward approaches that address immune balance and potentially reverse disease processes. An emphasis on integrative therapies here could lead to breakthroughs that fundamentally alter how we treat and understand autoimmune conditions, giving hope to millions who live with these challenging diagnoses.

A revitalized NIH would organize these efforts to create Centers of Excellence and Affiliated Integrative Health Centers dedicated to each priority area, using NIH’s existing structures to promote cross-disciplinary collaboration. These centers would operate as hubs of innovation and expedite rapid adoption, equipped with modular teams that could adapt rapidly to new discoveries or shifts in public health needs. Collaborations with universities, hospitals, and international health organizations would ensure each center has access to the expertise and resources needed to advance their missions. By leveraging NIH’s vast network, these Centers of Excellence would lead the charge in pushing the boundaries of scientific research within their specialized fields.

Increasing NIH’s extramural funding would support a nationwide ecosystem of independent research. By providing grants to universities and research institutions that demonstrate a commitment to objectivity and transparency, NIH could encourage high-quality studies free from external influence. Such a decentralized research environment would allow for a diversity of approaches, empowering scientists to explore innovative solutions to today’s most pressing health issues. Extramural funding would prioritize institutions willing to investigate complex health questions with an open mind, ensuring that NIH-supported research is guided by evidence and real-world needs rather than by financial or political pressures. This investment in academic independence would foster a more balanced scientific landscape where public trust in research could flourish.

Transparency would be the cornerstone of this new NIH, with public accessibility to research findings at every stage. NIH would mandate that all funded studies disclose adverse effects, share data openly, and publish findings through open-access platforms. Making this information readily available for public scrutiny not only strengthens NIH’s accountability but also equips independent researchers, policymakers, and the public with the knowledge needed to make informed decisions. By aligning NIH’s policies with open science principles, this approach reinforces the agency’s dedication to improving public health through honest, transparent research.

Finally, the ultimate measure of NIH’s success would be how effectively it translates research findings into actionable health interventions. This vision includes a robust transformative research commitment that ensures discoveries in labs make their way to clinics, hospitals, and communities. NIH would work alongside healthcare providers and public health organizations to understand and then implement evidence-based practices across all communities. Transformative pathways would bridge the gap between NIH research and practical applications, and community-based pilot programs would illustrate the benefits of integrative, preventive healthcare. With this focus, NIH’s contributions would extend beyond academia, helping to transform healthcare practices across the country.

This vision of transformative medicine for NIH—powered by a renewed commitment to integrative health, preventative care, and scientific transparency—could set the stage for a healthier future. We will set scientists free to be scientists and free physicians to be healers. Through increased extramural funding, the formation of Centers of Excellence, Affiliated Integrative Health Centers, and a deep commitment to objectivity, NIH can catalyze progress in treating iatrogenic illnesses, mental health disorders, metabolic diseases, and autoimmune conditions. A revitalized NIH would prioritize Americans’ health needs, pursuing research that is guided by evidence and dedicated to advancing true public well-being. With these reforms, NIH could lead a new era in public health do its part to Make America Healthy Again.